Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,501 | 415 | 99.3% |
| Education | $59.15 | 4 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,909 | 123 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,115 | 44 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $633.59 | 27 | $0 (2021) |
| Philips Electronics North America Corporation | $538.41 | 24 | $0 (2020) |
| Genentech USA, Inc. | $425.13 | 24 | $0 (2022) |
| Mylan Specialty L.P. | $421.63 | 26 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $336.48 | 22 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $254.57 | 12 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $233.25 | 13 | $0 (2020) |
| ADVANCED RESPIRATORY, INC | $225.14 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $513.32 | 12 | GlaxoSmithKline, LLC. ($156.94) |
| 2023 | $113.55 | 5 | GlaxoSmithKline, LLC. ($88.68) |
| 2022 | $636.35 | 21 | Boehringer Ingelheim Pharmaceuticals, Inc. ($179.69) |
| 2021 | $532.18 | 26 | GlaxoSmithKline, LLC. ($165.78) |
| 2020 | $723.03 | 40 | GlaxoSmithKline, LLC. ($259.77) |
| 2019 | $2,362 | 117 | GlaxoSmithKline, LLC. ($406.32) |
| 2018 | $1,762 | 96 | GlaxoSmithKline, LLC. ($311.61) |
| 2017 | $1,918 | 102 | GlaxoSmithKline, LLC. ($375.38) |
All Payment Transactions
419 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $153.83 | General |
| Category: VTE | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/17/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: RESPIRATORY | ||||||
| 06/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: RESPIRATORY | ||||||
| 05/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: RESPIRATORY | ||||||
| 03/27/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $140.02 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: RESPIRATORY | ||||||
| 03/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 01/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: RESPIRATORY | ||||||
| 09/22/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: RESPIRATORY | ||||||
| 11/09/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 11/03/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2022 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Airway Clearance Device | ||||||
| 09/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.90 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/23/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,380 | 2,553 | $545,505 | $267,204 |
| 2022 | 15 | 1,432 | 2,706 | $506,685 | $247,056 |
| 2021 | 16 | 1,275 | 2,510 | $529,048 | $259,260 |
| 2020 | 14 | 1,316 | 2,596 | $591,470 | $284,112 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 221 | 534 | $231,756 | $94,031 | 40.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 302 | 774 | $124,614 | $76,309 | 61.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 250 | 495 | $84,645 | $49,335 | 58.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 105 | 109 | $33,121 | $14,851 | 44.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $20,094 | $9,160 | 45.6% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 164 | 280 | $18,622 | $8,729 | 46.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 43 | 47 | $4,371 | $2,267 | 51.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 44 | 48 | $3,040 | $2,222 | 73.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 31 | 32 | $3,487 | $2,118 | 60.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $2,487 | $1,543 | 62.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 44 | 48 | $5,184 | $1,512 | 29.2% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 13 | 13 | $2,211 | $1,493 | 67.5% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 19 | 19 | $7,464 | $1,309 | 17.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $2,088 | $1,253 | 60.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 18 | 27 | $1,107 | $829.71 | 75.0% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 20 | 21 | $1,215 | $244.02 | 20.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 311 | 1,031 | $165,895 | $87,901 | 53.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 132 | 343 | $148,862 | $61,634 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 197 | 340 | $58,140 | $35,609 | 61.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 108 | 112 | $34,944 | $18,513 | 53.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 140 | 186 | $21,576 | $12,872 | 59.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 74 | 74 | $19,388 | $10,729 | 55.3% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 150 | 233 | $15,611 | $7,800 | 50.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 38 | 41 | $4,633 | $2,464 | 53.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $3,956 | $2,166 | 54.7% |
About Dr. Ayman Saad, M.D
Dr. Ayman Saad, M.D is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1669679718.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ayman Saad, M.D has received a total of $8,560 in payments from pharmaceutical and medical device companies, with $513.32 received in 2024. These payments were reported across 419 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($8,501).
As a Medicare-enrolled provider, Saad has provided services to 5,403 Medicare beneficiaries, totaling 10,365 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Pasadena, CA
- Active Since 07/02/2007
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1669679718
Products in Payments
- TRELEGY ELLIPTA (Drug) $807.65
- STIOLTO RESPIMAT (Drug) $572.07
- ANORO (Drug) $437.05
- NUCALA (Biological) $411.56
- inCourage (Device) $363.67
- SYMBICORT (Drug) $356.74
- STIOLTO (Drug) $294.75
- Yupelri (Drug) $224.71
- ZERBAXA (Drug) $220.14
- BREO (Drug) $192.73
- BEVESPI AEROSPHERE (Drug) $190.17
- Esbriet (Biological) $188.66
- Adempas (Drug) $172.20
- BROVANA (Drug) $171.85
- BEVYXXA (Drug) $167.88
- ELIQUIS (Drug) $161.78
- FLOWTRIEVER CATHETER, S (Device) $153.83
- The Vest System Model 105 Home Care (Device) $140.70
- ACTHAR (Biological) $140.02
- Da Vinci Surgical System (Device) $131.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882